Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

New London IPOs hit 28-year low amid AstraZeneca exit concerns

London has been distinguished by the first half of the first year of the size of the public subscription since 1997, and it is a dark teacher with a a report Astrazneca PLC CEO wants to transfer the company’s list to the United States.

With the presence of companies where liquidity is running abundant, the constant is reduced from the companies that are taken in particular, and a very small number of primary general offers that come to replace them, the pressure is escalating over the unlikely irreversible contraction of the historical trading location in London. Bloomberg’s accounts showed that more than $ 100 billion from London -listed companies have announced plans to move to New York in recent years.

The Times newspaper reported on Monday that the CEO of Astrazeneca wants to transfer the list of the drug maker’s stock to the United States. The exit from the stock exchange by the most valuable British company will send shock waves across the financial sector, and risk inviting more companies to join the flow of confidence lists that leave the city.

It would make the task of attracting new subscriptions more difficult. The companies that included in London have raised less than 200 million pounds ($ 274 million) in the past six months, according to the data collected by Bloomberg, and a turnover of stocks such as Astrazeneca is much larger for their depositors in the United States.

The Astrazneca step would accelerate the frightening trend of companies voluntarily transfer their lists to the United States. Wise Plc is the latest collection, and detection last month Its basic list to New York will move in search of better liquidity and new investors, in the footsteps of Fltertainment PLC, CRH PLC and Indivio PLC.

As for material, the trend towards the UK companies are receiving acquisitions this year, which may remove them from the stock exchange. Spectris Plc, DeliveroOO PLC and Assura PLC are among 48 suspended or complete deals since January 1 that target companies in London, the data collected by Bloomberg Show.

“The volume of integration and purchases and the lack of subscription subscriptions leads to a material decrease in the number of growth companies listed in the United Kingdom,” Charles Hall, the head of research at Peel Hunt, said in a research note. “We are witnessing continuous capital flows in the UK, which must be processed through pensions, ISA, and reforming stamp fees.”

Optimization of the subscription taps again

The manufacturers of the deal says that the second half of the year may witness a few subscriptions to subscriptions in the market, which may pave the way for a stronger recovery than 2026.

“We expect a temporary recovery in the fourth quarter with a number of transactions that were not completely done before the summer vacation,” said Tom Pacon, a partner in the M&A team in BCLP and corporate financing team. “This will not be to reopen everyone strong that everyone hopes, but it can start building some momentum.”

The MHA PLC professional services company was the largest offers so far in 2025, when it collected 98 million pounds on beginners AIM in London. Meanwhile, the Cobalt Holdings PLC Glencore canceled what could have been the largest in London in London, and the fast retail company has transferred public subscription preparations to Hong Kong from London, and people familiar with the matter He said.

Some of the companies that were reported are considering the public subscription in London this year are NewPrinches Spa in Italy, Banco Santander Sanander SA, and Ozbek Gold Miner Navoi Mining & Metallurgical Co.

The largest batch will come next year from the planned public subscription of 19 billion euros (22.4 billion dollars). The HG Capital Equival Group initially chose the British capital for inclusion, which was attracted by the listing reforms in London, especially an incoming base that allows the arrows provided by the euro to the leading FTSE indicators, according to Bloomberg.

“There is no waiting list from the subscriptions lined in London, but there are some candidates there,” said Andreas Burnestorf, head of the capital markets, shares at BNP Paribas SA.

European problem

It can be said that London is more difficult than the most difficult among the European stock exchanges, but it is not alone. Europe has suffered from the worst in the first half in relation to the subscriptions of public subscription in more than a decade, as Porters in Milan, Paris and Zurich witnessed less sizes than London, the data collected by Bloomberg. Part of the case this year was the fluctuation attack by US President Donald Trump’s tariff, which closed the market for weeks and prompted some exporters to delay their plans for the public.

Lists in London, where the capital has not been raised, presented a glimmer of hope. Last month, Valterra Platinum Ltd from Anglo American America completed a secondary list in London, in the footsteps of Paper International, which added the London list as part of its seizure of DS Smith PLC competition. Metlen Energy & Metals SA in Greece said last week that she expects to start trading in London in early August, although it will not collect any money.

Certainly, the United Kingdom was the most crowded place in Europe for the sales volume group in general so far this year given the grace in the follow -up versions, including the 5 billion pounds of stocks that were sold by Pfizer Inc. At Sensodyne-Maker Haleon PLC. Rosebank Industries PLC, which was included last year in Exchange, managed to collect 1.14 billion pounds from investors to finance a acquisition in the United States.

“For companies that have a convincing stock story and a strong management team, the London market works very effectively.”

Leave a Reply

Your email address will not be published. Required fields are marked *